Database : HANSEN Search on : RECIDIVA [Subject descriptor] References found : 55 [refine] Displaying: 1 .. 20   in format [Detailed]

page 1 de 3

go to page

1 / 55

HANSEN

select to print

Id: 18384 Author: Biswas, S; Mondal, K. K Title: Multidrug therapy in leprosy can prevent relapse- a retrospective study ..- Source: s.l; s.n; 2002. 6 p. . Abstract: A retrospective study was done at the Leprosy Control Unit (LCU) in Durgapur of Burdwan district, West Bengal, to determine the relapse rate following multidrug therapy (MDT). A total of 1581 patients (1276 PB and 305 MB) completed MDT regimens during a period of 5 years as per WHO recommendations and National Leprosy Eradication Programme (NLEP) guidelines. The treated patients were kept under surveillance as per NLEP guidelines and searched for relapses. The results of MDT were compared with those of pre-MDT (monotherapy) era at the same centre (total: 405 patients; PB-373, MB-32) andalso with those of the Leprosy Clinic in Gopalpur (only dapsone was given to a total of 189 patients, PB-167, MB-22) Following monotherapy, the relapse rate was 10.06% at the Gopalpur Leprosy Clinic and 12.4% at the Dargapur LCU during the 2 years (PB) and 5 years (MB) of surveillance, whereas following MDT no relapse case was encountered both in PB and MB cases during the surveillance periods recommended by WHO. The results of this study are comparable with those of ohter studies. Though a few studies showed relapses during long-term surveillance beyond the periods recommended by WHO, it is once again established that MDT can prevent relapse in leprosy (AU). Descriptors: HANSENIASE/quimioter HANSENIASE/epidemiol HANSENIASE/prev RECIDIVA/prev - HANSENOSTATICOS/admin  HANSENOSTATICOS/hist  HANSENOSTATICOS/normas  HANSENOSTATICOS/uso terap  CLOFAZIMINA/uso terap  DAPSONA/uso terap  RIFAMPINA/uso terap Limits: ESTUDO COMPARATIVO HUMANO Location: BR191.1; 09310/s

2 / 55

HANSEN

select to print Texto Completo

Id: 18339 Author: Fleury, Raul Negrão. Title: Relapses in leprosy. Source: Hansen. int;31(1):[4-6], 2006. . Descriptors: HANSENIASE/diag HANSENIASE/microbiol HANSENIASE/patol RECIDIVA/prev Limits: ESTUDO COMPARATIVO Electronic Medium: Internet Location: BR191.1

3 / 55

HANSEN

select to print Texto Completo

Id: 18338 Author: Fleury, Raul Negrão. Title: Recidivas em hanseníase / Relapses in leprosy Source: Hansen. int;31(1):1-3, 2006. . Descriptors: HANSENIASE/diag HANSENIASE/microbiol HANSENIASE/patol RECIDIVA/prev Limits: ESTUDO COMPARATIVO Electronic Medium: Internet Location: BR191.1

4 / 55

HANSEN

select to print

Id: 18328 Author: Wade, H. W Title: Relapsed and borderline cases of tuberculoid leprosy ?- Source: s.l; s.n; 1941. 15p p. ilus. Abstract: The question of the prospect for absolute cure, oron the other hand that of transformation to the lepromatous type, of active major tuberculoid cases, especially those that at one time or another have been found bacteriologically positive, is discussed. Out of twelve such cases observed at Cebu for several years, no less than seven have relapsed at one time or another after apparently complete recession of the disease. In one instance there had been a period of five years without trouble. It is suggested that the feature of relapse in tuberculoid leprosy is worthy of more attention than it has received. Lepromatous transformations has not as yet occurred in any of these cases. Two of them, however, have persisted for three years and more in an unstable, borderline condition, the picture dominated by repeated papular eruptions, the lesions atypical clinically and histologically. Another borderline case of decidelly different aspect seen in China is cited; it presented at the same time apparently lepromatous, tuberculoid and intermediate lesions and was looked upon as transitional, yet later recession occurred as is common in ordinary tuberculoid leprosy...AU. Descriptors: HANSENIASE DIMORFA/diag HANSENIASE DIMORFA/epidemiol HANSENIASE DIMORFA/imunol HANSENIASE DIMORFA/microbiol HANSENIASE TUBERCULOIDE/diag HANSENIASE TUBERCULOIDE/epidemiol HANSENIASE TUBERCULOIDE/imunol HANSENIASE TUBERCULOIDE/microbiol HANSENIASE DIMORFA/compl HANSENIASE TUBERCULOIDE/compl - RECIDIVA  HOSPITAIS DE DERMATOLOGIA SANITARIA DE PATOLOGIA TROPICAL/clas  HOSPITAIS DE DERMATOLOGIA SANITARIA DE PATOLOGIA TROPICAL/hist  HOSPITAIS DE DERMATOLOGIA SANITARIA DE PATOLOGIA TROPICAL/util  ANTIGENO DE MITSUDA/anal  ANTIGENO DE MITSUDA/imunol Limits: RELATO DE CASO Location: BR191.1; 01062/s

5 / 55

HANSEN

select to print

Id: 17969 Author: Chung VQ; Moschella SL; Zembowicz A; Liu V Title: Clinical and pathologic findings of paraneoplastic dermatoses Clinical and pathologic findings of paraneoplastic dermatoses-v.54 Source: s.l; s.n; 2006. 17 p. ilus. Abstract: Paraneoplastic dermatoses comprise a heterogeneous group of noninherited skin conditions that manifest internal malignancy. Familiarity with paraneoplastic dermatoses is important to both clinician and pathologist alike, as recognition of such a condition offers opportunity for early diagnosis and treatment of internal malignancy; monitoring for tumor recurrence; and insight into pathophysiology which may yield possible clues to treatment. Herein are reviewed 16 of the best established paraneoplastic dermatoses that display distinctive clinical and pathologic findings. LEARNING OBJECTIVE: At the conclusion of this leaning activity, participants should be able to recognize, diagnose, and describe the clinical and pathologic findings of paraneoplastic dermatoses...(AU). Descriptors: NEOPLASIAS/compl NEOPLASIAS/diag NEOPLASIAS/genet NEOPLASIAS/mortal NEOPLASIAS/fisiopatol NEOPLASIAS/reabil NEOPLASIAS/terap RECIDIVA LOCAL DE NEOPLASIA/compl RECIDIVA LOCAL DE NEOPLASIA/genet RECIDIVA LOCAL DE NEOPLASIA/fisiopatol - DERMATOPATIAS/compl Limits: ESTUDO COMPARATIVO HUMANO Location: BR191.1; 00320/cme

6 / 55

HANSEN

select to print

Id: 17513 Author: Donner, Robert S; Shively, John A Title: The "Lucio Phenomenon" in diffuse leprosy ..- Source: s.l; s.n; 1967. ^f831^l836 p. ilus. Descriptors: Amputação Cotos de Amputação Hipersensibilidade/CO Perna/SU Hanseníase Necrose/ET Recidiva Local de Neoplasia Neoplasias de Tecido Muscular/SU Complicações Pós-Operatórias Pele/BS Manifestações Cutâneas/* Doenças Vasculares/ET/PA Histiócitos Limits: RELATO DE CASO Location: BR191.1; 00874/s

7 / 55

HANSEN

select to print

Id: 14332 Author: Shetty, V. P; Wakade, A. V; Antia, N. H; Pai, V. V; Revencker, C. R; Ganapati, R; Bulchand, H. O. Title: Investigación clínica, histopatológica y bacteriológica en 2 casos de recidivas al finalizar tratamiento ROM. Source: Fontilles - Revista de Leprología;23(2):171-175, May.-Ago. 2001. . Descriptors: HANSENIASE HANSENIASE/quimioter HANSENIASE/microbiol HANSENIASE/patol RECIDIVA/prev RECIDIVA Electronic Medium: http://www.ilsl.br Location: BR191.1

8 / 55

HANSEN

select to print

Id: 14095 Author: Girdhar, B. K; Girdhar, Anita; Kumar, Anil. Title: Recidivas en pacientes de lepra multibacilares: resultado de la duración del tratemiento. Source: Fontilles - Revista de Leprología;22(5):481-495, May.-Ago. 2000. tab, graf. Abstract: Se comparan dos grupos de pacientes MB: uno tratado hasta negatividad en frotis (TSN) y el otro con terapia de duración fija (24 dosis MB OMS) (FDT), para determinar los índices de recidivas durante el tratamiento y el período post-tratamiento, encontrando 20 recidivas (2.04/100 pacientes/año) durante el seguimiento de 980.2 personas/año en 260 pacientes tratados en FDT. En el otro grupo , 301 pacientes recibieron tratamiento hasta negativización, detectándose 12 recidivas en 1085.46 personas/año (1.10/100 pacientes año). La comparación de los índices de supervivencia (sin recidivas) revela que aunque no hay diferencia significativa hasta los 4 años, el riesgo de recidiva es significativamente mayor en el grupo FDT durante un período mayor de seguimiento. Además, cuando se compara en los pacientes la carga bacilar inicial, se observa un índice de recidivas mayor en el grupo con IB≥4, significativamente mayor (p<0.01) que en el grupo FDT comparado con el grupo que recibe tratamiento hasta la completa negativización del frotis (4.29 años 1.27/100 pacientes/años). Todos los pacientes con recidivas respondieron al tratamiento con la misma combinación de medicamentos, indicando qu la exacerbación de su condición es por insuficiente tratamiento. Se sugiere para prevenir o reducir recidivas, el continuar cuando sea posible el tratamiento hasta negativización del frotis, al menos en pacientes con IB elevado. (AU). Descriptors: HANSENIASE/quimioter HANSENIASE/prev RECIDIVA/prev Electronic Medium: http://www.ilsl.br Location: BR191.1

9 / 55

HANSEN

select to print

Id: 13943 Author: Murray, Clinton K; Joyce, M. Patricia; Longfield, Robert N Title: Short report: treatment failure in Hanse´n's disease ..- Source: s.l; s.n; 2003. 2 p. tab. Abstract: Areas of low endemicity of Hansen's disease, such as Texas, California, and Hawaii, exist due to immigration and rare autochthonous infections. Managing this disease in these areas of low endemicity is difficult, especially in observing for relapse. The accurate diagnosis of relapse is imperative so that appropriate therapy can be promptly reinstituted and unnecessary treatment can be avoided. To assess treatment failures in an area of low endemicity, we retrospectively evaluated 113 patients with Hansen's disease treated in southern Texas. Of 57 patients who completed therapy, 11 were later restarted on medications for this disease for presumed relapse. However, nine of the 11 were found not to have true relapses of Hansen's disease. The accurate diagnosis of relapse of this disease is essential not only in the individual patient but also for prospective treatment trials to establish best practices. (AU). Descriptors: CLOFAZIMINA/admin DAPSONA/admin QUIMIOTERAPIA COMBINADA HANSENIASE/quimioter HANSENIASE/epidemiol HANSENIASE/patol HANSENIASE/prev REGISTROS MEDICOS RECIDIVA ESTUDOS RETROSPECTIVOS RIFAMPINA/admin TEXAS/epidemiol FALHA DE TRATAMENTO RECUSA DO PACIENTE AO TRATAMENTO Limits: HUMANO MASCULINO FEMININO CRIANÇA ADULTO MEIA-IDADE IDOSO ADOLESCENTE Electronic Medium: http://www.ilsl.br Location: BR191.1; 09084/s

10 / 55

HANSEN

select to print

Id: 13476 Author: Kuntz, J. L; Meyer, R; Vautravers, P; Kieffer, D; Asch, L Title: Polyarthrites au cours de la lèpre Polyarthritis in leprosy- Source: s.l; s.n; December 15, 1979. 4 p. . Abstract: Inflammatory rheumatisms simulating rheumatoid arthritis belong to the manifestations of the reactions of leprosy. Pathology of these arthritis variate with the type of reaction. In the present observations, it must probably be the transition from a tuberculoid leprosy to a lepromatosis form in which the immunological state looks like the lupus one.(AU). Descriptors: RECIDIVA LUPUS ERITEMATOSO SISTÊMICO/diag HANSENIASE/compl HANSENIASE/diag HANSENIASE/imunol DIAGNOSTICO DIFERENCIAL ARTRITE REUMATOIDE/diag ARTRITE INFECCIOSA/etiol Limits: RELATO DE CASO HUMANO FEMININO MEIA-IDADE RESUMO EM INGLES Electronic Medium: http://www.ilsl.br Location: BR191.1; 01557/s

11 / 55

HANSEN

select to print

Id: 13455 Author: Russell, D. A; Worth, R. M; Jano, B; Fasal, P; Shepard, C. C Title: Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia ..- Source: s.l; s.n; May 1979. 5 p. tab. Abstract: The 1,659 non-leprous people in a Micronesian population experiencing an annual leprosy incidence rate of about 7/1,000 were offered 15 acedapsone (DADDS) injections during 1967--1970 for leprosy prevention purposes. Subsequent annual surveillance showed an initial cessation of new cases during the 3-year DADDS campaign, followed by a resumption of cases thereafter at a yearly level of about 2/1,000 with a longer pause and slower rise among those who received the full regimen. A secondary wave of cases that has occurred since 1973 among children born after 1968 shows that post-campaign transmission occurred, probably principally from relapsing multibacillary cases with onset before the campaign. Recommendations are made for a balanced, long-term control program with DADDS preventive treatment limited to contacts of multibacillary cases.(AU). Descriptors: RECIDIVA RESISTÊNCIA MICROBIANA A DROGAS DAPSONA/analog HANSENIASE/epidemiol HANSENIASE/prev HANSENIASE/transm ACEDAPSONA/uso terap Limits: HUMANO CRIANÇA ADULTO SUPPORT, U.S. GOV'T, P.H.S. Electronic Medium: http://www.ilsl.br Location: BR191.1; 00464/s

12 / 55

HANSEN

select to print

Id: 13364 Author: McAdam, K. P; Anders, R. F; Smith, S. R; Russell, D. A; Price, M. A Title: Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy ..- Source: s.l; s.n; September 27, 1975. 4 p. tab, graf. Abstract: Rectal biopsy in 190 inpatients at a leprosy hospital in the Highlands of Papua New Guinea disclosed 16 patients with secondary amyloidosis. This represented 20% of the patients who had had polar lepromatous leprosy (L.L.) for more than 2 years. Patients with amyloidosis characteristically had either a history of recurrent attacks of erythema nodosum leprosum (E.NH) reactions or chronic trophic ulcers. Levels of the serum component (protein SAA) antigenically related to the amyloid fibril protein AA were monitored, at varying intervals for three months, in lepromatous patients with E.N.L. reaction. The SAA levels rose during E.N.L. reactions in parallel with the neutrophil count. SAA occurred with greatest frequency among patients with LH, while most non-lepromatous patients with detectable SAA had chronic trophic ulcers. The correlation between raised neutrophil count and elevated SAA concentration, observed in this and other studies, suggests that neutrophils are associated with the production of SAA.(AU). Descriptors: AMILOIDOSE/sangue AMILOIDOSE/etiol CONTAGEM DE LEUCOCITOS RECIDIVA HANSENIASE/sangue HANSENIASE/compl LEUCOCITOSE/sangue ERITEMA NODOSO/compl ERITEMA NODOSO/etiol Limits: HUMANO Electronic Medium: http://www.ilsl.br Location: BR191.1; 01790/s

13 / 55

HANSEN

select to print

Id: 13362 Author: Rao, P. T; Jena, S. K Title: Surgical treatment of plantar ulcers in leprosy ..- Source: s.l; s.n; 1986. 4 p. tab. Abstract: Plantar ulcers present a serious problem in the management of leprosy. After studying the mechanism of ulceration and the causes of their indolence, it appears that the treatment of the disease by antileprotic drugs is not sufficient. The underlying causes, such as anaesthesia, bony deformities and paralysis, should usually be treated by surgical means. Anaesthesia can be reversed by decompression of the posterior tibial nerve if this is done early. Deformities should be corrected by procedures on the soft tissues or bones, and chronic infection eradicated to prevent recurrence of the ulceration. A combination of procedures may sometimes be needed.(AU). Descriptors: DOENCAS DO PE/etiol DOENCAS DO PE/cirurg HANSENIASE/compl METODOS ESTUDOS PROSPECTIVOS RECIDIVA ULCERA CUTÂNEA/etiol ULCERA CUTÂNEA/cirurg Limits: HUMANO Electronic Medium: http://www.ilsl.br Location: BR191.1; 01917/s

14 / 55

HANSEN

select to print

Id: 11750 Author: Cambau, Emmanuelle; Bonnafous, Pascale; Perani, Evelyne; Sougkoff, Wladimir; Ji, Baohong; Jarlier, Vicent Title: Molecular detection of rifampin and ofloxacin resistance for patients Who experience relapse of multibacillary leprosy ..- Source: s.l; s.n; 2002. 7 p. tab. Descriptors: DNA BACTERIANO MYCOBACTERIUM LEPRAE MYCOBACTERIUM LEPRAE OFLOXACINA RECIDIVA RIFAMPINA ANTIBIOTICOS ANTITUBERCULOSE DNA TOPOISOMERASE (ATP-HIDROLISANTE) DNA TOPOISOMERASE (ATP-HIDROLISANTE) MODELOS ANIMAIS DE DOENÇAS TESTES DE SENSIBILIDADE MICROBIANA HANSENIASE MUTAÇAO PROTEINAS DE PLANTAS PROTEINAS DE PLANTAS Location: BR191.1; 08526/s; BR191.1; 08659/s

15 / 55

HANSEN

select to print

Id: 11727 Author: Sehgal, Virendra N; Kumar, Sunil; Jain, Sanjiv; Bhattacharya, Samit N Title: Relapse (reactivation) in borderline tuberculoid (BT) leprosy ..- Source: s.l; s.n; 1998. 2 p. ilus. Descriptors: HANSENIASE DIMORFA HANSENIASE DIMORFA HANSENIASE TUBERCULOIDE HANSENIASE TUBERCULOIDE LEPROSTATICOS AGENTES ANTIINFECCIOSOS DE FLUOROQUINOLONA ANTIBIOTICOS TETRACICLINICOS DAPSONA GRANULOMA HISTIOCITOS LINFOCITOS MINOCICLINA RECIDIVA RIFAMPINA Limits: ADULTO HUMANO MASCULINO Location: BR191.1; 07324/s

16 / 55

HANSEN

select to print

Id: 11698 Author: Poon, Alexander; MacLean, Hector; McKelvie, Penelope Title: Recurrent scleritis in lepromatous leprosy ..- Source: s.l; s.n; 1998. 5 p. ilus. Descriptors: HANSENIASE LEPROMATOSA HANSENIASE LEPROMATOSA HANSENIASE LEPROMATOSA MYCOBACTERIUM LEPRAE CAMARA ANTERIOR ANTIBIOTICOS QUIMIOTERAPIA COMBINADA ENUCLEAÇAO OCULAR INFECÇOES OCULARES BACTERIANAS INFECÇOES OCULARES BACTERIANAS INFECÇOES OCULARES BACTERIANAS SEGUIMENTOS LEPROSTATICOS RECIDIVA ESCLERA ESCLERITE ESCLERITE ESCLERITE Location: BR191.1; 08491/s

17 / 55

HANSEN

select to print

Id: 11694 Author: Suite, M Title: Relapse rates following leprosy multidrug therapy ..- Source: s.l; s.n; 2000. 2 p. . Descriptors: HANSENIASE HANSENIASE QUIMIOTERAPIA COMBINADA LEPROSTATICOS LEPROSTATICOS RECIDIVA ESTUDOS RETROSPECTIVOS TRINIDAD E TOBAGO Location: BR191.1; 08486/s; 08488/s

18 / 55

HANSEN

select to print

Id: 11625 Author: Machado, Cristiane Chaves Nascentes Title: Avaliação dos pacientes que obtiveram alta do tratamento específico no período de janeiro/1987 a fevereiro/1995, no Setor de Dermatologia da UFMG ?- Source: Belo Horizonte; s.n; 1997. xii,217 p. tab, graf. Thesis: Present for Universidade Federal de Minas Gerais. Faculdade de Medicina presented for the degree Mestre. Abstract: Uma variedade de manifestações dermatoneurológicas e psicossociais tem sido observadas em pacientes hansenianos, mesmo após o tratamento específico. É por esse motivo que, no presente trabalho, foram estudados pacientes hansenianos que já haviam recebido alta terapêutica no período de janeiro de 1987 a fevereiro de 1995. O estudo foi realizado no Ambulatório de Dermatologia do Hospital das Clínicas da Universidade Federal de Minas Gerais, Brasil. Avaliou-se o estado dos pacientes sob os aspectos clínicos e neurológicos, considerando as diferentes formas de tratamento e a classificação da hanseníase. Para tanto os pacientes foram avaliados em quatro períodos diferentes, antes do tratamento, momento da alta terapêutica, após o tratamento e exame proposto (realizado pela autora). Uma avaliação do aspecto psicossocial dos pacientes considerados neste estudo foi realizada no exame proposto. Foram analisados 243 prontuários e, embora tenham sido enviadas cartas de convocação para todos os pacientes, apenas 122 compareceram ao exame, sendo que, destes, 41 o fizeram de forma espontânea. Dos 122 pacientes examinados, 34,5 por cento eram paucibacilares e 65,5 por cento multibacilares, verificou-se também que 52,9 por cento haviam recebido esquema poliquimioterápico; outros 25,6 por cento esquema DNDS que, posteriormente, foi substituído por poliquimioterapia; e os restantes 21,5 por cento haviam recebido apenas esquema DDS. Foi observado somente um caso de recidiva. Observou-se, também, uma ocorrência maior de reação tipo I/II, de troncos nervosos espessados e de grau de incapacidade diferente de zero entre os pacientes multibacilares. Através da avaliação psicossocial, verificou-se que a maioria dos pacientes havia contado para a família sobre sua condição de portador de hanseníase. Pôde-se também constatar que um grande número de indivíduos que não se sentiam curados foi encontrado no grupo de pacientes que havia sofrido modificação terapêutica e naqueles que apresentaram reações. Quanto à auto-avaliação sobre cura da hanseníase, não se observaram diferanças significativas entre os pacientes com grau de incapacidade 0 ou 1 em relação aqueles com grau de incapacidade 2 ou 3. Observou-se ainda neste estudo que um grande número de pacientes se auto-discrimina. (AU). Descriptors: SINTOMAS CLINICOS RECIDIVA EXAME NEUROLOGICO CARENCIA PSICOSSOCIAL HANSENIASE HANSENIASE HANSENIASE HANSENIASE HANSENIASE HANSENIASE HANSENIASE HANSENIASE HANSENIASE Location: BR191.1; WC335.900, M119a

19 / 55

HANSEN

select to print

Id: 10974 Author: Buhrer-Sekula, S; Cunha, M. G. S; Foss, N. T; Oskam, L; Faber, W. R; Klatser, P. R Title: Dipstick assay to identify leprosypatients who have an increased risk of relapse ..- Source: s.l; s.n; 2001. 7 p. tab. Descriptors: HANSENIASE HANSENIASE HANSENIASE MYCOBACTERIUM LEPRAE ELISA GLICOLIPIDIOS RECIDIVA FATORES DE RISCO SENSIBILIDADE E ESPECIFICIDADE ANTICORPOS ANTIBACTÉRIAS Location: BR191.1; 07331/s

20 / 55

HANSEN

select to print

Id: 10340 Author: Becx-Bleumink, Marijke Title: Success of the WHO multidrug therapy? ..- Source: s.l; s.n; 1994. 4 p. tab. Descriptors: PROTOCOLOS CLINICOS RESISTENCIA MICROBIANA A DROGAS QUIMIOTERAPIA COMBINADA PREVISOES INCIDENCIA LEPROSTATICOS HANSENIASE HANSENIASE AVALIAÇAO DE PROGRAMAS RECIDIVA SISTEMA DE REGISTROS RESULTADO DE TRATAMENTO ORGANIZAÇAO MUNDIAL DA SAUDE Location: BR191.1; 07191/s

---

page 1 de 3

go to page

Refine the search

Database : HANSEN

Advanced form

Search for : Free form

		Search	in field
1			WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
2	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
3	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type

Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO Latin American and Caribbean Center on Health Sciences Information